We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Absorption Systems and its ACF Bioservicessubsidiary announced that they have been certified by the European Medicines and Healthcare products Regulatory Agency (MHRA).
Cambrex has entered into a definitive agreement to acquire Avista Pharma Solutions for roughly $252 million. Avista is a portfolio company of Ampersand Capital Partners.
These potency assays range from relatively simple protocols to more complex and elaborate designs that determine the mechanism of action of a gene therapy product.
Synthetic Genomics, Inc. and Advaxis, Inc. have completed development and deployment of the first cGMP synthetic biology facility for the production of synthetic DNA constructs.